[Treatment of toxoplasmosis].
D006801:Humans; D007167:Immunotherapy; D011739:Pyrimethamine / Q000627:therapeutic use; D013450:Sulfones / Q000627:therapeutic use; D014123:Toxoplasmosis / Q000188:drug therapy / Q000628:therapy*; D014125:Toxoplasmosis, Congenital / Q000188:drug therapy / Q000628:therapy
D013450:Sulfones; D011739:Pyrimethamine
Lechenie toksoplazmoza.